Company ProfilePremium

Taekwang Industrial Co. Ltd.

Company Profile Analysis

Ticker: 003240.KS

ESOMAR 23 Corporate BadgeISO Certifications Badge
Taekwang Industrial Co. Ltd. - Chemicals & Materials showcase

Year Founded & Workforce

1950

819 Employees

Industry

Chemicals & Materials
Taekwang Industrial Co. Ltd. logo

Taekwang Industrial Co. Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Taekwang Industrial Co. Ltd. Overview

Taekwang Industrial is the listed flagship of the Taekwang Group and one of Korea's oldest synthetic-fibre and petrochemical producers. It was the first Korean company to commercialise spandex, in 1979, and it remains a leading domestic acrylonitrile (AN) supplier from its Ulsan complex. Its legacy portfolio of purified terephthalic acid (PTA), acrylonitrile, sodium cyanide, acrylic fibre, nylon filament and spandex has been hit by Chinese overcapacity. The result is four consecutive annual operating losses (FY2022–FY2025) and revenue shrinking from about KRW 2.6 trillion to KRW 1.83 trillion. Its financial character is the opposite of distressed: it holds about KRW 1.5 trillion in net cash and liquid securities and almost no debt, and it carries a large equity-method stake of about 28% direct (about 45% group-wide) in Lotte Home Shopping. Since mid-2025 management has pursued a KRW 1.5 trillion "survival" restructuring into K-beauty, healthcare, hotels and real estate, under intense activist scrutiny over governance and minimal shareholder returns.


Company's own description

Taekwang describes itself as a vertically integrated producer spanning petrochemical raw materials through finished fibre and yarn. Third-party profiles drawn from its filings describe the business as petrochemicals, synthetic fibres, textiles and advanced materials, sold in Korea and internationally (S&P/Simply Wall St description).

Petrochemical products: purified terephthalic acid (PTA), propylene, acrylonitrile (AN), sodium cyanide (NaCN), acetonitrile, ammonium sulphate and hydrogen peroxide.

Synthetic fibres: acrylic fibre, nylon filament, spandex, spun yarns and low-melting fibre (the LMF line has since been exited).

Other materials: polyester fabrics and aramid fibre.

Non-manufacturing activities: property rental and a broadcasting/communications activity.

In its 29 September 2025 shareholder letter, then-CEO Yoo Tae-ho framed the company as standing at a crossroads between "elimination or leap" (paraphrased). The letter set two strategic axes:

  1. Strengthen the existing business through "selection and concentration": prune loss-making lines and expand proven high-margin specialties such as modacrylic, aramid and NaCN.

  2. Build a new portfolio in K-beauty, real-estate development, hotels and energy.

Reported segments

SegmentShare of consolidated revenue (2Q26)
Manufacturing & LeasingAbout 94%
Broadcasting & TelecommunicationsAbout 6%

On a consolidated basis, Taekwang reports two operating segments:

Source: Butler.works summary of the 2Q26 report.

Business and revenue model

Taekwang's revenue is almost entirely product revenue from commodity and semi-specialty chemicals and fibres, plus minor rental and broadcasting/telecom income. There are no subscription or licensing streams of note.

A large share of economic earnings comes from below the operating line:

  • equity-method income from associates, chiefly Lotte Home Shopping;

  • returns on a securities portfolio.

This explains why net income was positive in FY2022, FY2024 and FY2025 despite operating losses. For example, S&P data show equity-investment gains of KRW 229.3 bn in FY2024 and KRW 90.2 bn in FY2025.

Value-chain position

StageInputs boughtProducts made and sold
PetrochemicalsParaxylene, propylene and ammonia-type feedstocks (bought in)PTA, used by polyester makers
——AN, sold to ABS/NBL resin makers (LG Chem was a JV partner and offtaker) and used captively in acrylic fibre
FibresCaptive or purchased intermediatesAcrylic, nylon and spandex for textile mills and apparel supply chains
Specialties—NaCN for gold mining; aramid for protective, optical-cable and rubber-reinforcement uses; modacrylic for wigs

Taekwang sits in the midstream of the petrochemical-to-textile chain:

Customer types and end-markets

End-marketProductsCustomer type
Polyester chain (fibre, PET)PTAPolyester fibre/resin producers (B2B)
Plastics and synthetic rubber (appliances, autos, gloves)ANABS/NBL producers (B2B)
Apparel, knitwear, sportswearAcrylic, spandex, nylon filamentSpinners, knitters, weavers (B2B, export-heavy)
Hair goods (wigs, extensions)ModacrylicWig manufacturers, mostly overseas
Gold miningSodium cyanideGlobal miners and distributors
Defence, telecom, tyresAramidProtective-gear, optical-cable and tyre/rubber makers
Electronics and chemical processingHydrogen peroxide, acetonitrileIndustrial users
Consumer beauty and household (from 2026, via associates)Aekyung Industrial (2080 toothpaste, Kerasys) and Dongsung Pharmaceutical (Seven Eight hair dye, minoxidil)Retail and online consumers
HospitalityCourtyard by Marriott Seoul Myeongdong (group REIT)Travellers

Independent characterisation

Taekwang is best understood as three overlapping businesses:

  1. A shrinking commodity manufacturer. Petrochemicals and fibres are structurally challenged by Chinese capacity additions.

  2. A cash-rich holding vehicle. Book equity is about KRW 4.0 trillion, against a market value of about KRW 1.0 trillion. The balance sheet holds liquid assets, real estate (management cites over KRW 1 trillion of property value) and strategic stakes (Lotte Home Shopping, group financial affiliates).

  3. An emerging consumer and real-estate platform built through 2025–2026 M&A.

The equity story is dominated by governance: the controlling family's influence, persistent sub-1% dividend payout, a 24.41% treasury-share block, and the question of whether acquisitions serve minority shareholders or family succession.

Strategy

Stated strategy (themes, paraphrased from the Sep 2025 letter, Apr 2026 letter and Jun 2026 value-up plan)

  1. Crossroads framing. Management argues the company must restructure or decline because of Chinese overcapacity, raw-material volatility and slowing global demand.

  2. Selection and concentration in the core. Exit low-return lines (PTA Plant 2, LMF, cotton spinning, China spandex, some nylon) and expand proven high-margin specialties (modacrylic, aramid, NaCN).

  3. New growth axes. K-beauty and healthcare (Aekyung, Dongsung, SIL), real-estate development and hotels (Marriott Myeongdong), and energy (self-supply first, then energy-business revenue, aligned with carbon-neutrality and EU green trends).

  4. Capital allocation. "All-in" investment of about KRW 1.5 tn across 2025–2026, while maintaining a no-borrowing stance as far as possible.

  5. Communication. More shareholder letters, an upgraded ESG Support Office, and board-centred management.

Strategic initiatives, last 24 months

InitiativeDateScope / targetStatus (Oct 2026)
KRW 1.5 tn restructuring investment roadmap1 Jul 2025About KRW 1 tn in 2025, the rest in 2026; cosmetics, energy, real estateAbout KRW 884 bn deployed in Aekyung, Marriott and Dongsung (Dealsite)
Existing-business reinvestmentJul 2025Over KRW 500 bn planned for petrochemicals and fibresCapex KRW 151.8 bn in FY2025
Reserve operating fundJul 2025KRW 560 bn (3.5 years of operating needs) ring-fencedPolicy
Treasury-share EB (KRW 318.6 bn)27 Jun 20253-year, 0% coupon, exchange price KRW 1,172,251Withdrawn 24 Nov 2025
China exitJul 2025–Jun 2026Halt and sell the Changshu spandex plantCompleted (sold CNY 143 m)
Articles amendment1 Oct 2025About 10 new business purposes added (cosmetics, real estate, hotels, energy, REIT/PFV investment, blockchain finance)Completed
K-beauty entryOct 2025–Mar 2026Aekyung acquisition; SIL launchClosed
Healthcare/dermaJan–May 2026Dongsung Pharmaceutical rescueRehabilitation exit under way
Hotel/real estateDec 2025Courtyard Marriott Seoul (KRW 254.2 bn)Closed
ShipbuildingNov 2025–presentK Shipbuilding bidFirst process failed Jun 2026; rebid under review (Sep 2026)
Financial expansion (group)2025–2026IGIS AM (failed); KDB Life (Heungkuk Life final bid Aug 2026)KDB pending
ESG governance upgrade2,025ESG team raised to an officeCompleted
2026 Corporate Value Enhancement Plan30 Jun 20262030 revenue KRW 5 tn; ROE 8%; treasury shares as M&A currency; treasury holding/disposal plan to the 2027 AGMCriticised by Truston

Medium-term targets and guidance

TargetBaseline (FY2025)2030 targetSource
RevenueAbout KRW 1.8 tnKRW 5 tnValue-up plan (NewDaily, Jul 2026)
ROEAbout 2%8%Same
Dividend payoutAbout 1%No quantified target (Truston demands 10% in 2026 rising to 40% by 2030)Edaily
Treasury shares24.41% heldHolding/disposal plan to be put to the 2027 AGMEdaily (Sep 2026)

No annual earnings guidance is published.

Products & Services

Pricing is not publicly disclosed for any product; all are sold at negotiated or market-index prices.

Petrochemicals

ProductDescription and key characteristicsTarget customerCapacity, latest dataStatus
Purified terephthalic acid (PTA)Main raw material for polyester fibre and PET resin, made from paraxylenePolyester fibre/film/resin producers—Petrochemical plant No. 2 shut in 2025 amid Chinese oversupply
Acrylonitrile (AN)Monomer for ABS, NBL (nitrile gloves), acrylic fibre and carbon fibreResin makers (formerly LG Chem offtake), captive acrylic fibre290 kt/yr at Ulsan Plant 3, plus TL Chemical's planned 260 kt/yrDomestic share 33.3% (2019, KPIA handbook)
Sodium cyanide (NaCN)AN co-product chain derivative; leaching reagent for gold miningGlobal gold minersExpansion "accelerating" (Sep 2025 letter)Growth specialty
AcetonitrileAN co-product; solvent for pharma and electronicsPharma/electronics solvent users—Ongoing
Ammonium sulphateAN co-product; fertiliserFertiliser distributors—Ongoing
Hydrogen peroxide (H2O2)Oxidant and bleach; electronic grades used in semiconductorsPulp/paper, textiles, electronics—Ongoing
PropyleneOlefin feedstockInternal use and merchant sale—Ongoing

Synthetic fibres and textiles

ProductDescription and key characteristicsTarget customerNotes
Spandex ("ACELAN" brand)Elastane fibre for stretch apparel, hosiery and medical textilesKnitters/weavers, global apparel supply chainKorea's first (1979). China plant closed 2025; Korean production continues
Acrylic fibreWool-substitute staple and tow for knitwear and blanketsSpinners and knitwear makersBackward-integrated with captive AN
ModacrylicFlame-retardant acrylic copolymer used as wig and hair-extension fibreWig manufacturers (Africa/US demand)Growth specialty per the Sep 2025 letter
Nylon filamentNylon 6 filament yarn for apparelWeavers/knittersSome nylon lines flagged for shutdown (Jul 2025)
Aramid fibreHigh-strength para-aramid for ballistic/protective gear, optical-cable strength members and rubber reinforcementDefence/protective, telecom cable, tyre makersExpansion under way (Sep 2025 letter)
Polyester fabricsIncluding black abaya fabric for Middle East marketsMiddle East apparel wholesalersOngoing
Spun yarn / cotton yarnCotton spinningWeaversCotton-spinning mill withdrawn (Sep 2025 letter)
Low-melting fibre (LMF)Bicomponent binder fibre for nonwovensNonwoven and automotive felt makersExited 2025
Raincoats, umbrellas, safety clothingHistorical wet-weather and safety apparel lines (Wikipedia)Consumers/industry—

Leasing and real estate

AssetDescriptionNotes
Property rentalRental of owned real estate; management cites over KRW 1 tn of real-estate valueTruston alleges KRW 301.2 bn was spent on real-estate-related ventures over two years, including the Dosan Park building (KRW 20 bn)
Courtyard by Marriott Seoul Myeongdong (formerly Namdaemun)4-star, 400 rooms, opened 2016; bought from KT&G for KRW 254.2 bn via a Heungkuk REIT vehicleManagement calls it the starting point of a real-estate development axis

Consumer, beauty and healthcare (new, 2026)

BusinessFlagship brands and productsNotes
Aekyung Industrial (31.56%)2080 (toothpaste), Kerasys (shampoo), Spark (detergent), AGE20's and Luna (cosmetics)Over 20 years of uninterrupted profit and about KRW 50 bn annual EBITDA (Dealsite, Sep 2025). Q2 2026 OP KRW 4.5 bn (-59.4% YoY); overseas sales share 42%
Dongsung Pharmaceutical (consortium)Jeongrohwan (antidiarrhoeal), Seven Eight (hair dye), minoxidil (hair-loss treatment), Phonozen (photodynamic anti-cancer candidate in Phase 2)Plan described as a "total beauty-healthcare platform" with Aekyung
SILCosmetics brand companyReported target: derma-cosmetics in the mould of APR's "medicube" (Dealsite, Jan 2026)

Broadcasting and telecommunications

A residual segment providing about 6% of revenue. Product detail is not disclosed in the sources reviewed.

Financial Narrative

Source for all tables: S&P Global Market Intelligence via StockAnalysis.com (consolidated, KRW M, FY Jan–Dec). Ratios and per-share values are derived by this analyst. Per-share values use about 841,631 outstanding shares (ex-treasury), implied by dividends paid ÷ KRW 1,750.

Income statement

Notes:

Net income: shown is total net income. Attributable-to-parent figures per Butler.works are KRW 318.4 bn, 342.2 bn, -14.7 bn, 218.4 bn and 83.1 bn (KRW 100M basis: 3184, 3422, -147, 2184, 831), which conflict slightly with S&P.

Diluted EPS: equals basic: no dilutive instruments are outstanding after the 2025 EB withdrawal.

DPS: is derived from cash dividends paid (KRW 1,473 M per year for FY2022–FY2025) and the KRW 1,750 FY2025 dividend confirmed by StockHub/Wisesheets (ex-date 30 Mar 2026). The FY2021 dividend is assumed at KRW 1,750 based on the FY2022 cash payment.

Revenue CAGR FY2021–FY2025: -8.4% a year.

Commentary. FY2021 was a super-cycle peak: post-COVID restocking and record spreads in AN and spandex delivered a 13.7% operating margin and a record KRW 355 bn operating profit (company-reported). From 2022, Chinese capacity additions in PTA, spandex and acrylics compressed spreads to near zero:

  • gross margin collapsed to 3.8% in FY2022;

  • the company posted operating losses in four consecutive years (company basis).

FY2024 showed partial gross-margin recovery (9.4%) from cost cuts and the end of loss-making lines. FY2025 revenue fell another 9.9% as PTA plant No. 2 and the LMF line closed. SG&A rose 14% on restructuring and new-business costs, driving a -2.0% operating margin.

Net income has been decoupled from operations: equity-method gains (Lotte Home Shopping and other associates) and portfolio returns turned operating losses into net profits in FY2022 and FY2024. FY2025 net income of KRW 80.8 bn included a KRW 42.2 bn asset write-down and restructuring charge.

Q1 2026 revenue was KRW 533.3 bn with an operating loss of KRW 11.4 bn (Sateconomy, Jun 2026). TTM revenue to March 2026 was KRW 1.873 tn with an operating loss of KRW 56.2 bn (S&P), so losses persisted into 2026.

Balance sheet

Commentary. The balance sheet is exceptionally conservative. Management describes 75 years of a "no-borrowing principle" (Sep 2025 letter).

Debt: fell to KRW 9.1 bn at end-FY2025 after KRW 168.7 bn of short-term debt was repaid.

Liquidity: cash plus liquid securities of about KRW 1.55 tn equals about 39% of equity.

Book value: BVPS of about KRW 4.67 m against a share price of about KRW 0.9 m explains the 0.2x P/B.

FY2024 investments: long-term investments dropped by about KRW 745 bn while other long-term assets rose by about KRW 600 bn. This reflects reclassification of the SK Broadband stake to held-for-sale, sold in May 2025 for about KRW 777.6 bn (Dealsite).

FY2025 working capital: jumped to KRW 2.03 tn as sale proceeds were parked in short-term financial products (KRW 818 bn at 1H25 per Dealsite).

2026 outlook: cash deployment of about KRW 884 bn across Aekyung, the Marriott hotel and Dongsung (Dealsite) will reduce liquidity during 2026.

Cash flow

Commentary. Operating cash flow is volatile and was negative in FY2025 (-KRW 133 bn), driven by:

  • non-cash equity gains reversing out (-KRW 90 bn);

  • working-capital build: inventory +KRW 40 bn and other net operating assets -KRW 52 bn;

  • KRW 90.5 bn of cash taxes, likely on the SK Broadband gain.

Capex doubled to KRW 151.8 bn in FY2025. Specialty expansions (aramid, NaCN, modacrylic) and construction in progress rising to KRW 198 bn (from KRW 93 bn) are the drivers. TTM operating cash flow to June 2026 was -KRW 281.5 bn and TTM FCF -KRW 463.6 bn, signalling continued cash burn in the core business.

Shareholder returns are negligible. Dividends of about KRW 1.47 bn a year equal roughly 0.1% of book equity, and no buybacks or cancellations have occurred in five years.

Key ratios (derived)

Notes: the FY2022 net-debt/EBITDA figure is computed on negative EBITDA and is not meaningful (company-basis EBITDA was also negative). The ROIC approximation uses a 24.2% tax rate for FY2021; negative-OI years are shown pre-tax. All ratios use year-end balances.

Commentary. Ratios portray a company that is financially impregnable but economically under-earning.

ROE: has averaged about 4% over five years, of which roughly two-thirds came from associates and securities rather than operations. Management's own 2030 target of 8% ROE is below Korea's typical cost of equity, as Truston argues.

Asset turnover: has eroded from 0.53x to 0.41x as revenue shrank while the asset base stayed mostly intact.

Working capital: the cash conversion cycle widened to 62 days in FY2025 on the inventory build.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentContentsProducts/servicesApprox. share of revenue (2Q26)

Manufacturing & Leasing

Petrochemical and fibre manufacturing at Ulsan; property leasing

PTA, AN, NaCN, acetonitrile, ammonium sulphate, H2O2, propylene; acrylic, modacrylic, nylon filament, spandex, aramid, polyester fabric; rental income

94%

Broadcasting & Telecommunications

Residual broadcasting/communications activity within the consolidated group (the cable-TV business T-broad was historically sold to SK Broadband)

Broadcasting/telecom services

6%

Revenue by Segment and Revenue by Segment (KRW)

MetricFY2021FY2022FY2023FY2024FY2025

Consolidated revenue, S&P (KRW Mn)

2,591,8462,606,5962,265,4902,027,5351,827,440

Consolidated operating income, S&P (KRW Mn)

353,931-104,478-99,370-395-36,015

Consolidated revenue, company-reported per Korean media (KRW 100M)

25,91827,03821,26320,27518,274

Consolidated operating income, company-reported per Butler.works (KRW 100M)

3,553-1,221-994-272-360

Product Group Details

Product groupApprox. shareApprox. revenue (KRW 100M)YoYComment

Petrochemicals

76%13,900-16%

PTA, AN, NaCN and derivatives

Fibres

13%2,400-5%

Acrylic, modacrylic, nylon, spandex, aramid

Other (leasing, broadcasting/telecom)

About 11%

——

Residual

“—” = not publicly disclosed.

Group Entities

EntityRelationshipActivityStatus

TL Chemical Co., Ltd.

100% subsidiary since Dec 2025 (60% from 2021)

Acrylonitrile production, Ulsan

Bought out LG Chem's 40% (1.48 m shares) for about KRW 49.1 bn

Taekwang Synthetic Fiber (Changshu) Co., Ltd.

Former 100% subsidiary

Spandex, China

Halted 2025; sold Jun 2026 for CNY 143 m

Lotte Home Shopping (Woori Home Shopping)

Associate: Taekwang 27.99% direct; group about 45% with Daehan Synthetic Fiber 10.21% and Tcis 6.78%

TV home shopping

Board reshaped to 6 Lotte : 3 Taekwang (Mar 2026)

Aekyung Industrial (KRX: 018250)

31.56% held directly; co-controlled with "Beauty Life One" SPC (T2 PE/Yuanta), also 31.56%

Household and cosmetics (2080, Kerasys, AGE20's, Luna)

Closed 26 Mar 2026

Dongsung Pharmaceutical (KRX: 002210)

Member of the UAMCO-led consortium holding 72.45%

OTC drugs, hair dye, hair-loss care

Rehabilitation-exit process (spring 2026)

SIL (실)

Newly established cosmetics subsidiary

K-beauty brand vehicle

Established 2025

TRN Co.

Taekwang holds 3.32%

Group de facto holding company (Lee Ho-jin 51.83%, Lee Hyun-joon 39.36%)

—

Koryo Savings Bank

Taekwang 20.2% (2021 data)

Savings bank

—

T2 Private Equity (reported)

Taekwang 41%, Tcis 41%, Lee Hyun-joon 9%, Lee Hyun-na 9% (per CEO Score Daily)

PE GP used in group deals

Governance concern raised by Truston and the press

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (KRW Mn)

2,591,8462,606,5962,265,4902,027,5351,827,440

Revenue growth (%)

48.90.6-13.1-10.5-9.9

Cost of revenue (KRW Mn)

2,032,4192,507,4942,163,1521,836,1521,652,022

Gross profit (KRW Mn)

559,42899,103102,338191,383175,417

SG&A (KRW Mn)

182,136177,962166,110160,479183,293

Operating income (KRW Mn)

353,931-104,478-99,370-395-36,015

Depreciation & amortisation (KRW Mn)

57,97060,14266,06842,87240,673

EBITDA, OI + D&A (KRW Mn)

411,901-44,336-33,30242,4774,658

Gain on equity investments (KRW Mn)

37,558317,139157,846229,27990,182

Net income (KRW Mn)

316,364256,658-18,502214,53180,824

EPS, basic, derived (KRW)

375,894304,953-21,983254,89996,033

EPS, diluted (KRW)

375,894304,953-21,983254,89996,033

Dividend per share (KRW)

1,7501,7501,7501,7501,750

Gross margin (%)

21.63.84.59.49.6

Operating margin (%)

13.7-4.0-4.40.0-2.0

EBITDA margin (%)

15.9-1.7-1.52.10.3

Net margin (%)

12.29.8-0.810.64.4

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (KRW Mn)

4,922,4624,820,7444,738,2924,722,2784,498,283

Cash & equivalents (KRW Mn)

356,851477,540336,621390,360426,477

Cash + short-term investments + trading securities (KRW Mn)

1,454,2741,241,3621,265,6241,434,3721,549,600

Long-term investments (KRW Mn)

1,681,9921,867,6641,902,8631,157,6071,259,398

Short-term debt incl. current leases (KRW Mn)

101,14581,13085,88893,1954,359

Long-term debt incl. leases (KRW Mn)

11,7847,01713,8447,1214,774

Total debt (KRW Mn)

112,92888,14799,732100,3169,133

Net cash, positive = net cash (KRW Mn)

1,341,3461,153,2161,165,8921,334,0551,540,467

Total equity (KRW Mn)

3,970,9134,122,7004,029,4994,015,5673,964,265

Goodwill + intangibles (KRW Mn)

61,03425,13323,64420,49718,337

Working capital (KRW Mn)

1,580,1591,509,2741,432,3651,562,8772,030,079

Book value per share (KRW)

4,625,1934,804,9704,689,7214,668,6104,669,556

Treasury stock (KRW Mn)

-284,629-284,629-284,629-284,629-284,629

Cash Flow and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (KRW Mn)

289,591-146,338106,938228,719-133,280

Capital expenditure (KRW Mn)

-85,096-61,812-78,513-79,166-151,845

Free cash flow (KRW Mn)

204,495-208,15028,425149,552-285,124

FCF margin (%)

7.9-8.01.37.4-15.6

Dividends paid (KRW Mn)

-1,304-1,473-1,473-1,473-1,473

Share buybacks (KRW Mn)

00000

Net debt issued/(repaid) (KRW Mn)

-18,075-32,067-11,178-10,512-91,727

Investing cash flow (KRW Mn)

-233,400296,869-237,498-165,359313,680

Cash income tax paid (KRW Mn)

13,597103,436-10,1569,35190,451

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2021FY2022FY2023FY2024FY2025

ROE (%)

8.06.2-0.55.32.0

ROA (%)

6.45.3-0.44.51.8

ROIC, approx., NOPAT/(equity + debt - liquid assets) (%)

10.2-4.0-3.60.0-1.1

Current ratio (x)

3.664.604.414.887.26

Debt/equity (%)

2.82.12.52.50.2

Net debt/EBITDA (x, negative = net cash)

-3.3-26.0-35.0-31.4-330.7

Interest coverage, OI/cash interest (x)

254.4-52.1-20.2-0.1-8.7

Asset turnover (x)

0.530.540.480.430.41

Days sales outstanding

67.456.365.062.565.7

Days inventory outstanding

35.735.325.329.541.6

Days payables outstanding

50.432.338.840.545.0

Cash conversion cycle (days)

52.759.351.551.562.3

Product Lines

Product linePrincipal geographies (qualitative)DirectionDriver

PTA

Korea and Asian polyester hubs

Declining

Chinese self-sufficiency; plant No. 2 closure

AN

Korea (ABS/NBL makers), Asia exports

Stable to declining

Chinese AN capacity additions; LG Chem exit from the JV

Spandex

Korea and formerly China (Changshu)

Sharply declining (China)

China plant losses of KRW 93.5 bn over 3 years; closure 2025

Modacrylic (wig fibre)

Export: Africa, North America hair-goods markets

Growing

Specialty demand cited by management

NaCN

—

Growing

Gold-price strength, geopolitical safe-haven demand (Sep 2025 letter)

Aramid

Global defence, telecom and tyre supply chains

Growing

Defence spending; optical-cable demand

Polyester fabric (abaya)

Middle East

——

Aekyung (associate)

Korea plus overseas (42% overseas in Q2 2026; global sales +35% YoY)

Growing overseas

K-beauty exports

Share Price History

DatePrice (KRW)Source

27 Jun 2025

1,103,000

Dealsite (EB pricing day)

4 Jul 2025

About 1,091,000 (intraday)

Asia Business Daily

Mid-Sep 2025

About 932,000

Hanwha Investment & Securities table

13 Nov 2025

About 860,000 (intraday high)

Chosun via TechLeap

16 Jul 2026

866,000

StockAnalysis

24 Jul 2026

891,000

HALO

6 Aug 2026

913,000

StockAnalysis

4 Sep 2026

901,000

ValueLine

16 Sep 2026

908,000

StockAnalysis

Valuation Multiples

MultipleTaekwangPeer comparison

P/E (TTM)

About 7.9–8.8x

—

P/B

About 0.22–0.25x

KOSPI average about 1x (context)

EV/EBITDA

Not meaningful: EV is negative (net cash exceeds market cap) and EBITDA is near zero; HALO shows -274x

n/m

EV/Sales

Negative EV, so not meaningful

n/m

Dividend yield

About 0.2%

—

Per-Share Data and Dividends & Capital Returns

MetricFY2021FY2022FY2023FY2024FY2025

Dividend per share (KRW)

1,7501,7501,7501,7501,750

Total dividends paid (KRW Mn)

1,3041,4731,4731,4731,473

Payout ratio (%)

0.40.6-8.00.71.8

Capital Markets

ItemDetail

Buybacks

None in five years; no current authorisation identified

Treasury shares

24.41%; EB monetisation withdrawn Nov 2025; holding/disposal plan to the 2027 AGM; value-up plan contemplates use as M&A currency

Credit ratings (Moody's, S&P, Fitch)

None; no rated public debt

Debt maturity profile

Total debt KRW 9.1 bn (FY2025), mostly leases (current KRW 3.5 bn; long-term KRW 4.8 bn); maturity risk negligible

Analyst consensus

No sell-side consensus identified. Individual brokers (e.g., Hanwha Investment & Securities) publish occasional notes.

Index / liquidity

KOSPI constituent; extreme illiquidity (free float about 230k shares)

Analyst Conclusions

Guidance and consensus

Management guidance: only long-range targets of KRW 5 tn revenue and 8% ROE by 2030 (Value-Up Plan, 30 Jun 2026). No annual guidance.

Consensus: not available.

Implied trajectory: reaching KRW 5 tn from about KRW 1.8 tn would require about 22% annual growth. That is only achievable through large consolidated acquisitions (e.g., shipbuilding or insurance-adjacent assets) rather than organic growth.

Bull case

  1. Deep asset discount. At about 0.23x book, with net cash and liquid securities of about KRW 1.54 tn exceeding the about KRW 1.0 tn market cap, investors effectively pay less than zero for the operating businesses, the Lotte Home Shopping stake and real estate. Any credible capital-return commitment, such as treasury cancellation at the 2027 AGM, could trigger a sharp re-rating.

  2. Core losses are narrowing structurally. Exiting the worst assets (China spandex with KRW 93.5 bn of 3-year losses, PTA Plant 2, LMF) and redeploying capex into aramid, modacrylic and NaCN could return manufacturing to break-even or profit by 2027.

  3. Regulatory tailwinds. Korea's Commercial Act reforms and value-up programme, plus persistent activist pressure, raise the probability of better shareholder returns over time.

Bear case

  1. Capital misallocation. Cash is flowing into diversified acquisitions with uncertain synergies. Aekyung's value dropped below its purchase price within months, and shipbuilding and insurance bids risk deploying further multi-hundred-billion-won sums, which TTM FCF of -KRW 463.6 bn makes more acute.

  2. Governance discount is entrenched. The family's control (about 40% plus 24.41% treasury), the around 1% payout, the owner's legal issues and alleged family-benefiting deal structures make the discount sticky regardless of fundamentals.

  3. No end to commodity pressure. Chinese overcapacity is structural, and the shrinking revenue base plus low R&D leave little moat in remaining lines.

Key catalysts and monitorables (next 12 months)

CatalystTimingWhy it matters
K Shipbuilding rebid follow-up disclosureFrom 6 Oct 2026Possible capital commitment of up to about KRW 900 bn
KDB Life outcome (Heungkuk Life)H2 2026Group leverage and intra-group funding risk
Truston actions (EGM request, derivative suit)Q4 2026Governance escalation
Q3 2026 resultsNov 2026Whether core losses are narrowing
Lotte Home Shopping litigationOngoingValue of a key associate stake
Lee Ho-jin criminal proceedingsOngoingGovernance and reputation
Treasury-share plan and 2027 AGM proposalsEarly 2027Single largest potential re-rating lever
Specialty capacity start-ups (aramid, NaCN, modacrylic)2026–2027Margin recovery
Aekyung and Dongsung turnaround metricsQuarterlyValidation of the beauty pivot
Third Commercial Act amendment (mandatory treasury cancellation)Legislative calendarCould force cancellation of the 24.41% block

Analyst verdict

Taekwang Industrial presents one of the starkest value-versus-governance dilemmas on the Korean exchange.

The balance sheet is formidable. About KRW 1.54 trillion of net cash and liquid securities and almost no debt support roughly KRW 4.0 trillion of book equity. Against that, the market assigns a capitalisation of only about KRW 1.0 trillion. By any conventional measure the stock trades below liquidation value.

The operating franchise has deteriorated sharply. Revenue has shrunk by about 30% since 2021, and four straight years of operating losses reflect a structural rather than cyclical squeeze from Chinese overcapacity. Management's response has two halves:

  • pruning legacy capacity and leaning into defensible niches (aramid, modacrylic, sodium cyanide), which is rational and overdue;

  • a parallel, rapid-fire diversification into beauty, pharmaceuticals, hotels, shipbuilding and group financial assets, which is far more contentious.

Early evidence is not encouraging. Aekyung's price had to be cut after a product recall, and its market value then fell well below the acquisition price. The K Shipbuilding process collapsed. The IGIS bid failed. Meanwhile, trailing free cash flow is deeply negative.

Governance is the decisive variable. A controlling family with a convicted, pardoned and reportedly re-indicted former chairman as "adviser" retains a 24.41% treasury block. Payout has averaged about 1% for a decade. Deal structures include vehicles part-owned by the founder's children. Until the board demonstrably aligns capital allocation with minority shareholders, the asset discount is likely to persist. The levers would be treasury-share cancellation, a credible payout path and transparent, arm's-length M&A.

Verdict. Taekwang is a deep-value, governance-contingent situation, not a fundamental growth story. Investors with a long horizon and tolerance for illiquidity may find the downside cushioned by net cash. However, the catalysts for value realisation sit largely outside management's demonstrated priorities: the 2027 AGM treasury-share plan, regulatory change, or activist litigation. Pending clearer evidence that new acquisitions earn their cost of capital and that capital will be returned, the appropriate stance is cautious neutrality, with an emphasis on monitoring governance catalysts over operating ones.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenure / appointmentBackgroundCompensation

Lee Bu-ui (이부의)

Co-CEO; Head of Existing Business (business division general manager)

Appointed business head 2025; inside director from 1 Oct 2025 EGM; co-CEO from 1 Apr 2026

Long experience in petrochemicals and fibres (Sep 2025 letter)

Not publicly disclosed (in verifiable form)

Jeong In-cheol (정인철)

Co-CEO; Head of Future Business

Recruited 2025 as VP heading the new Future Business Promotion Office; CEO from 1 Apr 2026

Led new-business discovery and investment across industries (Sep 2025 letter); sits on Aekyung's board

—

Yoo Tae-ho (유태호)

Former CEO (signed Sep 2025 letter)

—

Press describes him as Lee Ho-jin's "right hand" (Dealsite headline)

—

Lim Jeong-gyo (임정교)

Managing Director, Head of ESG Support Office

Appointed 2025 when the ESG team was upgraded

Finance and compliance background

—

Lee Ho-jin (이호진)

Non-standing adviser; former Group Chairman

Adviser since after the 2023 pardon

Convicted of embezzlement (released 2021, pardoned 2023); declined to register as a director in 2026, citing health. Press reports a new indictment on embezzlement/breach-of-trust charges in 2026 (Sateconomy, Jun 2026)

Not applicable

“—” = not publicly disclosed.

Governance Overview

AspectDetail

Notable outside director

Prof. Kim Woo-jin (SNU Graduate School of Business; governance specialist), nominated by Truston and appointed via the 2024 AGM as audit committee member

Independence

An outside-director majority is required for large KOSPI companies. Truston disputes substantive independence.

Group Management Council

An informal group-level body. Truston (Sep 2026) questions its influence over Taekwang's decisions and CEO appointments, and whether Lee Ho-jin attends or receives reports.

Board & Management Changes

DateChangeContext
2025

Future Business Promotion Office created; Jeong In-cheol hired

Restructuring programme

2025

Lee Bu-ui appointed business head

Turnaround of existing businesses

1 Oct 2025

Lee Bu-ui elected inside director (EGM)

—

1 Apr 2026

Co-CEO system: Jeong In-cheol plus Lee Bu-ui

The day after the AGM defeated activist proposals

Major Shareholders

HolderStakeSource / date

Lee Ho-jin (former chairman)

29.48%—

TRN Co. (Lee family company)

11.22%

Dealsite (2021)

Treasury shares

24.41% (271,769 shares)

Multiple, 2025–2026

Truston Asset Management

5.97% (2024); 5.95% (Mar 2025)

Asia Business Daily; Dealsite

Free float

About 230,000 shares (about 20% of issued)

Truston (Jul 2026)

Competitive Landscape

Competitors by Segment

Product lineCompetitorCountryPositioning vs Taekwang

Spandex

Hyosung TNC (creora)

Korea

Global #1 spandex; far larger scale

Spandex

Zhejiang Huafon Chemical

China

Low-cost Chinese leader; key source of overcapacity

Spandex

Xinxiang Chemical Fiber

China

Chinese scale producer

Aramid

Hyosung Advanced Materials (ALKEX)

Korea

Domestic aramid peer

Aramid

Kolon Industries (Heracron)

Korea

Leading Korean para-aramid producer

Aramid

DuPont (Kevlar), Teijin (Twaron)

US / Japan

Global incumbents

Acrylic / modacrylic

Aksa Akrilik

Turkey

World's largest acrylic fibre producer

Acrylic / modacrylic

Kaneka (Kanekalon)

Japan

Modacrylic wig-fibre leader

AN

Tongsuh Petrochemical

Korea

Main domestic AN competitor

AN

INEOS Nitriles, Asahi Kasei, Chinese producers

Global

Scale and technology leaders

PTA

Hanwha TotalEnergies, Hanwha Solutions; Chinese majors (Hengli, Rongsheng/Yisheng)

Korea / China

Chinese mega-scale has collapsed margins

NaCN

Cyanco, Orica, Draslovka, Australian Gold Reagents

US / Australia / Czechia

Global mining-chemical suppliers

Polyester / industrial fibre

Huvis

Korea

Domestic polyester fibre peer

Household & beauty (via Aekyung)

Amorepacific, LG H&H, APR

Korea

Aekyung is a mid-tier challenger

Competitor Detail

MetricTaekwang (FY2025)

Revenue

KRW 1.83 tn

Revenue growth

-9.9%

Operating margin

-2.0%

R&D intensity

About 0.01% (S&P line item)

Company Snapshot

$1,286M

Revenue

819

Employees

1950

Founded

Seoul, South Korea

Headquarters

SWOT Analysis

Strengths

  • Net cash of KRW 1.54 tn and total debt of only KRW 9.1 bn at FY2025 (S&P), equal to about 39% of equity in liquid form.
  • Book equity of about KRW 3.96 tn against a market cap of about KRW 1.0 tn, a P/B of about 0.23x, which leaves substantial asset backing.
  • A 33.3% domestic AN market share (2019), backward-integrated into acrylic and modacrylic.
  • Large associate earnings: equity-investment gains of KRW 229.3 bn (FY2024) and KRW 90.2 bn (FY2025), chiefly from the about 28% direct stake in Lotte Home Shopping.
  • Proven ability to monetise non-core assets: SK Broadband (about KRW 777.6 bn, 2025) and the China plant sale (KRW 34.8 bn, 2026).
  • Growth specialties identified: aramid, modacrylic and NaCN expansions, backed by FY2025 capex of KRW 151.8 bn (about double FY2024).

Weaknesses

  • Four consecutive annual operating losses (FY2022–FY2025) on the company basis (KRW -122.1 bn, -99.4 bn, -27.2 bn, -36.0 bn), followed by a Q1 2026 loss of KRW 11.4 bn.
  • Revenue down about 30% from FY2021 to FY2025 (KRW 2.59 tn to KRW 1.83 tn), a -8.4% CAGR.
  • Negative FY2025 FCF of KRW -285.1 bn, with TTM FCF at June 2026 of KRW -463.6 bn.
  • A dividend payout around 1%: KRW 1,750 per share (yield about 0.2%) and a 10-year average payout in the 1% range (Truston).
  • Disclosed R&D below KRW 0.3 bn a year (S&P line), about 0.01% of revenue.
  • Illiquid stock: free float of about 230,000 shares (Truston), with days of as few as 350 shares traded (KED, 2022).

Opportunities

  • K-beauty and derma platform: Aekyung's overseas share reached 42% in Q2 2026 with global sales +35% YoY.
  • Hair-loss and derma market of about KRW 4 tn in Korea, addressable via Dongsung (minoxidil, Seven Eight) together with Kerasys.
  • Treasury-share block (24.41%): cancelling it, as Truston urges, could re-rate per-share value. The board must put a holding/disposal plan to the 2027 AGM.
  • Korean "value-up" and Commercial Act reforms (July 2025 directors' fiduciary duty to shareholders) pressure discount compression.
  • Possible K Shipbuilding rebid (Sep 2026 disclosure), offering exposure to a shipbuilding upcycle and the US "MASGA" theme.
  • Over KRW 1 tn of real estate that could be developed or recycled through REIT structures (Heungkuk REITs vehicle).

Threats

  • Structural Chinese overcapacity in PTA, spandex and AN, which forced closure of PTA Plant 2, the LMF line and the China spandex plant.
  • Owner legal risk: Lee Ho-jin's reported 2026 indictment, plus his history of conviction and medical-bail controversy (Korea Times).
  • Activist escalation: Truston threatened an EGM, derivative suits and a criminal complaint (Sep 2026).
  • Acquisition-value risk: Aekyung was bought for about KRW 447.5 bn for 63%, yet its market cap fell to the KRW 300 bn range by Aug 2026 and Q2 OP dropped 59.4%.
  • Lotte Home Shopping dispute: board control lost (6:3) and legal action pending, which could impair a key earnings source.
  • Political and regulatory scrutiny of treasury-share use: lawmakers criticised the EB ruling, and a third Commercial Act amendment on mandatory treasury cancellation was under discussion in late 2025.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 2025Aekyung Group puts Aekyung Industrial up for saleSets up Taekwang's K-beauty entry
May 2025SK Broadband 16.75% stake sold to SK Telecom (about KRW 777.6 bn inflow)Major liquidity boost
19–26 Jun 2025T2 PE (affiliate) submits LOI for Aekyung and is short-listedDeal process
27 Jun 2025KRW 318.6 bn treasury-share EB announced (24.41% of shares; exchange price KRW 1,172,251)Triggers activist backlash
30 Jun 2025Truston files an injunction against the EBLegal conflict begins
1 Jul 2025KRW 1.5 tn restructuring plan; PTA Plant 2 and LMF closures disclosedStrategic pivot
1 Jul 2025FSS orders a correction of the EB filing (undisclosed counterparty)Regulatory pushback
2 Jul 2025EB process suspended pending the court rulingShare price rallies to about KRW 1.06–1.09 m
3 Jul 2025KRX notice of planned unfaithful-disclosure designation; Commercial Act amendment adds directors' duty to shareholdersGovernance pressure
Jul 2025Taekwang petitions financial regulators alleging market disruption by TrustonEscalation
30 Jul 2025China spandex subsidiary halted; KRW 100 bn capital injectionLoss elimination
1H 20251H operating loss about KRW 16 bn (company letter) or KRW 8.3 bn (Hanwha report); net income KRW 50.3 bn (-43.7%)Weak core
10 Sep 2025Court dismisses Truston's injunctionWin for management
12 Sep 2025Preferred bidder for Aekyung; MOU signedM&A milestone
29 Sep 2025First shareholder letter by CEO Yoo Tae-hoStrategy communication
1 Oct 2025EGM approves new business purposes; Lee Bu-ui elected directorLegal basis for the pivot
21 Oct 2025Aekyung SPA (63.12%, KRW 470 bn)Deal signed
12–13 Nov 2025Taekwang–TPG LOI for K Shipbuilding; shares reach about KRW 860,000Shipbuilding ambition
18 Nov 2025SPA for the Marriott Namdaemun hotelReal estate
24 Nov 2025EB withdrawn; TL Chemical buyout approved (KRW 49.1 bn)Funding plan reset
Dec 2025Marriott hotel acquisition completesNew asset class
29 Dec 2025Seoul Rehabilitation Court approves the UAMCO–Taekwang consortium for DongsungHealthcare entry
7 Jan 2026Taekwang board approves the Dongsung investment—
Feb 2026TPG exits the K Shipbuilding consortium; revised LOI 27 Feb—
12 Feb 2026Truston submits seven AGM proposals, including voluntary delistingActivism escalates
Feb–Mar 2026Aekyung price cut to KRW 447.5 bn; closing delayed to 26 Mar after the 2080 toothpaste recallDeal risk realised
12 Mar 2026Taekwang opposes Lotte Home Shopping CEO reappointment, alleging unfair related-party trading; pre-announces value-up planLotte dispute reignites
Mar 2026Lotte Home Shopping AGM reshapes board to 6 Lotte : 3 TaekwangTaekwang influence reduced
18 Mar 2026Dongsung rehabilitation plan vote (no capital reduction; 100% creditor repayment)—
26 Mar 2026Aekyung acquisition closesK-beauty platform
31 Mar 2026AGM defeats most Truston proposalsManagement prevails
1–2 Apr 2026Co-CEO system; shareholder letter on business restructuringLeadership change
Apr–May 2026Group ranks 48th in the FTC designation; assets over KRW 10 tnScale-up
14 May 2026Motion to dismiss Lotte Home Shopping CEO fails; Taekwang vows legal actionLitigation risk
May 2026Dongsung applies to exit rehabilitationTurnaround progress
1 Jun 2026Heungkuk Life joins the five-way preliminary KDB Life bidGroup financial M&A
Q1 2026Revenue KRW 533.3 bn; operating loss KRW 11.4 bnLosses persist
Jun 2026Press reports Lee Ho-jin indicted for embezzlement/breach of trustOwner legal risk (Sateconomy)
22 Jun 2026K Shipbuilding sale terminatedShipbuilding bid fails
Late Jun 2026China subsidiary sold for CNY 143 mExit complete
30 Jun 20262026 Value-Up Plan (2030: KRW 5 tn revenue, 8% ROE)Strategic targets
1 Jul 2026Truston calls the plan flawed (PBR 0.22x)Activism
14 Jul 2026Truston letter demanding a 40% payout by 2030 and at least a 5-for-1 splitActivism
7 Aug 2026Heungkuk Life submits final KDB Life bid (vs Hanwha Life and Korea Investment Holdings)Pending
14 Aug 20261H 2026 report filed; IR session announced 24 AugDisclosure
25–28 Aug 2026Aekyung Q2 OP KRW 4.5 bn (-59.4% YoY); market cap falls to the KRW 300 bn rangeAcquisition valuation under pressure
3 Sep 2026Truston letter on the Group Management Council; threatens EGM, derivative suit and criminal complaintGovernance escalation
7 Sep 2026Taekwang says it is considering a K Shipbuilding rebid; follow-up disclosure due 6 Oct 2026Possible re-entry
8 Sep 2026Truston rebuts Taekwang's allegations of illegal share-price demands and denies obstructing restructuringDispute continues

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Income Statement: Revenue & Gross Profit: Revenue fell from KRW 2,591.8 Bn in FY2021 to KRW 1,827.4 Bn in FY2025.
Taekwang Industrial Co. Ltd. — Income Statement: Revenue & Gross Profit
Series (KRW Bn)FY2021FY2022FY2023FY2024FY2025
Revenue2,591.82,606.62,265.52,027.51,827.4
Cost of revenue2,032.42,507.52,163.21,836.21,652
Gross profit559.499.1102.3191.4175.4

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

  1. StockAnalysis.com / S&P Global Market Intelligence: Taekwang Industrial income statement, balance sheet, cash flow (accessed Jul–Sep 2026)
  2. Korea Times, "Taekwang's rapid expansion seen as signal of disgraced owner's return" (7 Apr 2026)
  3. Bizhankook: EB opposition and Aekyung (2025); Aekyung price cut to KRW 447.5 bn (2026); co-CEO and shareholder letter (Apr 2026); KDB Life and M&A (Jun 2026); TRN governance structure
  4. Dealsite: EB issuance (30 Jun 2025); KRW 1.5 tn plan (1 Jul 2025); China spandex shutdown (31 Jul 2025); 1H25 cash flow and SK Broadband sale (Oct 2025); EB withdrawal (24 Nov 2025); TL Chemical buyout (24 Nov 2025); Dongsung (Jan–Mar 2026); China subsidiary sale (Jun 2026); K Shipbuilding/TPG (Nov 2025); KDB Life (Aug 2026); Aekyung Q2 2026 (Aug 2026); TL Chemical JV (2021)
  5. SmartToday: Taekwang shareholder letter, full text (29 Sep 2025); KRW 1.5 tn plan (Jul 2025)
  6. Asia Business Daily: Truston proposals (Feb 2026); Truston letters (Jul and Sep 2026); K Shipbuilding failure (Jun 2026); Aekyung process (2025); Truston 2024 proposals
  7. Edaily: Truston on the value-up plan (Jul 2026); Truston rebuttal (Sep 2026); Group Management Council (Sep 2026)
  8. NewDaily: 2026 value-up plan targets (Jul 2026)
  9. Hankyung, CEO Score Daily, Sateconomy: Lotte Home Shopping dispute (Mar 2026); Q1 2026 results (Jun 2026)
  10. Cosinkorea, HuffPost Korea, Dailypharm: Dongsung Pharmaceutical acquisition
  11. Daum / Business Post and The Fact: FTC ranking, Aekyung ownership, Marriott hotel
  12. KED Global: first quarterly loss in 10 years (Aug 2022)
  13. CEO Score Daily / Dailian: TL Chemical JV (Jun 2021)
  14. Butler.works, ValueLine, StockHub, HALO, Simply Wall St, PitchBook, Morningstar, Wisesheets, Parqet: market data, segment mix, employees, dividends
  15. WorldPorts / Seoul Economic Daily: K Shipbuilding consortium details
  16. TankTerminals / Reuters: Korean petrochemical restructuring (Dec 2025)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.